Limited repair and structural damages displayed by skeletal muscles loaded with mycolactone

Microbes and Infection

Volumn 11, Issue 2, 2009, Pages 238-244

  Houngbédji, Germain Mabèrou ^a   Côté, Claude H ^a   Small, Pamela L C ^b   Frenette, Jérôme ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Fibrosis; Inflammation; Mycobacterium ulcerans; Mycolactone; Necrosis; Skeletal muscle properties

Indexed keywords

BACTERIAL TOXIN; HYDROXYPROLINE; MYCOLACTONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BURULI ULCER; CHRONIC INFLAMMATION; CONTROLLED STUDY; HISTOPATHOLOGY; MACROPHAGE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CONTRACTURE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE LEVEL; MUSCLE NECROSIS; MUSCLE REGENERATION; MUSCLE RELAXATION; MUSCLE STIFFNESS; MUSCLE STRESS; MUSCLE TETANIC CONTRACTION; MUSCLE TWITCH; MUSCLE WEAKNESS; MYOFIBROSIS; MYOSITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SOLEUS MUSCLE;

MAMMALIA; MUS; MYCOBACTERIUM ULCERANS;

EID: 61449170914     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.11.016     Document Type: Article

References (22)

1. Torrado E., Adusumilli S., Fraga A.G., Small P.L., Castro A.G., and Pedrosa J. Mycolactone-mediated inhibition of TNF production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection. Infect. Immun. 75 (2007) 3979-3988
2. Peduzzi E., Groeper C., Schütte D., Zajac P., Rondini S., Mensah-Quainoo E., Spagnoli G.C., Pluschke G., and Daubenberger C.A. Local activation of the innate immune system in buruli ulcer lesions. J. Invest. Dermatol. 127 (2007) 638-645
3. Oliveira M.S., Fraga A.G., Torrado E., Castro A.G., Pereira J.P., Filho A.L., Milanezi F., Schmitt F.C., Meyers W.M., Portaels F., Silva M.T., and Pedrosa J. Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infect. Immun. 73 (2005) 6299-6310
4. George K.M., Chatterjee D., Gunawardana G., Welty D., Hayman J., Lee R., and Small P.L. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283 (1999) 854-857
5. Coutanceau E., Decalf J., Martino A., Babon A., Winter N., Cole S.T., Albert M.L., and Demangel C. Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J. Exp. Med. 204 (2007) 1395-1403
6. Gooding T.M., Johnson P.D., Campbell D.E., Hayman J.A., Hartland E.L., Kemp A.S., and Robins-Browne R.M. Immune response to infection with Mycobacterium ulcerans. Infect. Immun. 69 (2001) 1704-1707
7. Pahlevan A.A., Wright D.J., Andrews C., George K.M., Small P.L., and Foxwell B.M. The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function. J. Immunol. 163 (1999) 3928-3935
8. Torrado E., Fraga A.G., Castro A.G., Stragier P., Meyers W.M., Portaels F., Silva M.T., and Pedrosa J. Evidence for an intramacrophage growth phase of Mycobacterium ulcerans. Infect. Immun. 75 (2007) 977-987
9. George K.M., Pascopella L., Welty D.M., and Small P.L. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect. Immun. 68 (2000) 877-883
10. Plant D.R., Colarossi F.E., and Lynch G.S. Notexin causes greater myotoxic damage and slower functional repair in mouse skeletal muscles than bupivacaine. Muscle Nerve 34 (2006) 577-585
11. el-Dwairi Q., Comtois A., Guo Y., and Hussain S.N. Endotoxin-induced skeletal muscle contractile dysfunction: contribution of nitric oxide synthases. Am. J. Physiol. 274 (1998) C770-C779
12. Supinski G., Nethery D., Stofan D., and DiMarco A. Comparison of the effects of endotoxin on limb, respiratory, and cardiac muscles. J. Appl. Physiol. 81 (1996) 1370-1378
13. Stienstra Y., van Roest M.H., van Wezel M.J., Wiersma I.C., Hospers I.C., Dijkstra P.U., Johnson R.C., Ampadu E.O., Gbovi J., Zinsou C., Etuaful S., Klutse E.Y., van der Graaf W.T., and van der Werf T.S. Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop. Med. Int. Health 10 (2005) 1251-1257
14. Lapointe B.M., and Cote C.H. Anesthetics can alter subsequent in vitro assessment of contractility in slow and fast skeletal muscles of rat. Am. J. Physiol. 277 (1999) R917-R921
15. Frenette J., Chbinou N., Godbout C., Marsolais D., and Frenette P.S. Macrophages, not neutrophils, infiltrate skeletal muscle in mice deficient in P/E selectins after mechanical reloading. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R727-R732
16. Frenette J., St-Pierre M., Cote C.H., Mylona E., and Pizza F.X. Muscle impairment occurs rapidly and precedes inflammatory cell accumulation after mechanical loading. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002) R351-R357
17. Houngbédji M.G., Boissinot M., Bergeron G.M., and Frenette J. Subcutaneous injection of Mycobacterium ulceranscauses necrosis, chronic inflammatory response and fibrosis in skeletal muscle. Microbes infect. 10 (2008) 1236-1243
18. De Letter M.A., van Doorn P.A., Savelkoul H.F., Laman J.D., Schmitz P.I., Op de Coul A.A., Visser L.H., Kros J.M., Teepen J.L., and van der Meche F.G. Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J. Neuroimmunol. 106 (2000) 206-213
19. Hogan M.C., Gladden L.B., Grassi B., Stary C.M., and Samaja M. Bioenergetics of contracting skeletal muscle after partial reduction of blood flow. J. Appl. Physiol. 84 (1998) 1882-1888
20. Vaitkevicius P.V., Lane M., Spurgeon H., Ingram D.K., Roth G.S., Egan J.J., Vasan S., Wagle D.R., Ulrich P., Brines M., Wuerth J.P., Cerami A., and Lakatta E.G. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc. Natl. Acad. Sci. U S A 98 (2001) 1171-1175
21. Brinckmann J., Neess C.M., Gaber Y., Sobhi H., Notbohm H., Hunzelmann N., Fietzek P.P., Muller P.K., Risteli J., Gebker R., and Scharffetter-Kochanek K. Different pattern of collagen cross-links in two sclerotic skin diseases: lipodermatosclerosis and circumscribed scleroderma. J. Invest. Dermatol. 117 (2001) 269-273
22. Bruel A., Ortoft G., and Oxlund H. Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. Atherosclerosis 140 (1998) 135-145